The ellagic acid-derived gut microbiota metabolite, urolithin A, potentiates the anticancer effects of 5-fluorouracil chemotherapy on human colon cancer cells. Issue 5 (13th May 2015)

• Record Type: Journal Article
• Authors: González-Sarrías, Antonio; Tomé-Carneiro, Joao; Bellesia, Andrea; Tomás-Barberán, Francisco A.; Espín, Juan Carlos
• Is Part Of: Food & function. Volume 6:Issue 5(2015)
• Page Start: 1460
• Page End: 1469
• Publication Date: 2015-05-13
• Subjects: Food -- Analysis -- Periodicals; Food -- Composition -- Periodicals; Nutrition -- Periodicals; 664.07
• DOI: 10.1039/c5fo00120j
• Languages: English
• ISSNs: 2042-6496

Abstract

<abstract abstract-type="toc"> <title> <x xml:space="preserve">Abstract</x> </title> <p> <graphic position="anchor" id="ga" xlink:href="ark:/27927/pgjp07wr58" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink" />The ellagic acid-derived gut microbiota metabolite, urolithin A, at concentrations achievable in the human colorectum, enhances the anticancer effects of 5-FU-chemotherapy on three different colon cancer cells.</p> </abstract>